Published in Clin Exp Allergy on March 01, 2005
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med (1999) 3.44
The diagnosis and management of chronic cough. Eur Respir J (2004) 2.96
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 2.71
A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest (2001) 2.66
Inflammatory mediators of asthma: an update. Pharmacol Rev (1998) 2.54
ERS guidelines on the assessment of cough. Eur Respir J (2007) 2.36
Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax (2004) 2.36
Difficult asthma. BMJ (1989) 2.28
Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J (2001) 2.18
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Inflammatory mediators and asthma. Pharmacol Rev (1988) 2.17
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J (2004) 2.06
Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol (2009) 1.89
Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J (1994) 1.89
Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med (2007) 1.86
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med (1997) 1.84
Regulation of human lung epithelial cell numbers by diesel exhaust particles. Eur Respir J (2006) 1.79
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76
Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med (2000) 1.75
Role of inflammation in the hyperreactivity of the airways in asthma. Thorax (1986) 1.68
Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma. Clin Exp Allergy (2009) 1.67
Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med (1998) 1.65
Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med (1996) 1.65
Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med (2001) 1.63
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther (1986) 1.62
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax (2008) 1.62
Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol (1985) (1995) 1.58
Specific immunological and bronchopulmonary responses following intradermal sensitization to free trimellitic anhydride in guinea pigs. Clin Exp Allergy (1992) 1.57
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis (1990) 1.57
Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J (1998) 1.56
Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol (2001) 1.55
Efficacy of a cell phone-based exercise programme for COPD. Eur Respir J (2008) 1.52
Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol (1985) (1987) 1.50
Murine models of asthma. Eur Respir J (2003) 1.49
Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med (1996) 1.45
Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med (2000) 1.44
Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM (2003) 1.44
Management of difficult asthma. Br J Hosp Med (1994) 1.44
Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med (2004) 1.43
Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med (1999) 1.42
Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma. Thorax (1989) 1.41
Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med (2001) 1.41
IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol (2001) 1.38
Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol (1997) 1.38
Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J (1996) 1.35
Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med (1998) 1.34
PAF antagonists in asthma. Lancet (1989) 1.33
Systematic assessment of difficult-to-treat asthma. Eur Respir J (2003) 1.33
Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol (1989) 1.32
Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology (2002) 1.31
Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis (1990) 1.31
Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. Thorax (1990) 1.28
Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol (1999) 1.28
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med (1995) 1.27
Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo. Br J Pharmacol (1988) 1.27
Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med (2002) 1.27
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease. Histopathology (2004) 1.26
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax (2003) 1.26
Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis (1991) 1.23
Acupuncture for insomnia. Cochrane Database Syst Rev (2007) 1.22
Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol (1988) 1.21
Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet (1987) 1.21
Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax (1998) 1.20
Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax (2000) 1.20
Histamine dose-response relationships in normal and asthmatic subjects. The importance of starting airway caliber. Am Rev Respir Dis (1982) 1.18
Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol (1995) 1.17
Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. Am J Respir Crit Care Med (2000) 1.16
Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma. J Immunol (2001) 1.16
Fundamentals of pulmonary drug delivery. Respir Med (2003) 1.16
Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs. J Appl Physiol (1985) (1985) 1.15
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet (1990) 1.14
Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J (1990) 1.14
Effect of prior bronchoconstriction on the airway response to histamine in normal subjects. Thorax (1984) 1.13
Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. J Allergy Clin Immunol (1991) 1.13
Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol (1998) 1.13
Kyphoscoliosis and bronchial torsion. Chest (1997) 1.11
Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis (1986) 1.09
Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am J Respir Cell Mol Biol (2001) 1.07
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J (2001) 1.07
Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats. Am Rev Respir Dis (1992) 1.06
Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol (1994) 1.06
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur Respir J (2009) 1.05
Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax (2000) 1.04
Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology (1994) 1.04
Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med (1996) 1.04
Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. Am Rev Respir Dis (1988) 1.04
Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways. Am Rev Respir Dis (1991) 1.03
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax (2009) 1.03
Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology (1995) 1.03
Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. Br J Pharmacol (1988) 1.02
Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax (1999) 1.02
Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy (2001) 1.01
Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am J Physiol (1994) 1.01
Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol (1985) (1985) 1.00